IP Library Granted Patent US 8,500,677
Granted Patent B2
US 8,500,677 · App. 12/742,943 · Granted Aug 6, 2013

Power injector with flow rate assessment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,500,677
App. No.
12/742,943
Granted
Aug 6, 2013
Kind
B2
Abstract

A flow rate assessment protocol ( 140 ) that may be utilized by a power injector ( 10 ) is disclosed. This flow rate assessment protocol ( 140 ) monitors a flow rate ( 156 ) during execution of a medical fluid delivery protocol ( 154 ). This monitored flow rate is compared with a target flow rate ( 158 ). A comparative output of this monitored flow rate and target flow rate is displayed ( 160 ), for instance on a graphical user interface ( 11 ).

Claims (38)

1. A method of operation for a medical fluid delivery system, the method comprising the steps of:

discharging medical fluid from said medical fluid delivery system in accordance with a phase of a fluid delivery protocol, wherein said phase is configured to deliver a programmed volume of said medical fluid at a programmed target flow rate; and

displaying a first output, wherein said first output comprises a numerical comparison between a current flow rate of said discharging step and said target flow rate, wherein said numerical comparison comprises a single number, and wherein said discharging step is executed in an attempt to provide said target flow rate.

2. The method of claim 1 , wherein said discharging step comprises discharging said medical fluid from a power injector.

3. The method of claim 1 , wherein said discharging step comprises injecting said medical fluid into a fluid target.

4. The method of claim 3 , wherein said fluid target comprises a patient.

5. The method of claim 1 , wherein said displaying step comprises displaying said first output on at least one graphical user interface.

6. The method of claim 1 , wherein said displaying step is executed only when said current flow rate differs from said target flow rate by more than a predetermined amount.

7. The method of claim 1 , wherein said displaying step is continuously executed throughout said discharging step.

8. The method of claim 1 , wherein said displaying step comprises expressing said current flow rate as a percentage of said target flow rate.

9. The method of claim 1 , wherein said displaying step comprises displaying a differential between said current flow rate and said target flow rate.

10. The method of claim 1 , wherein said displaying step comprises conveying information as to how said current flow rate differs from said target flow rate.

11. The method of claim 1 , further comprising the step of:

issuing a message that conveys that said discharging step is failing to comply with said target flow rate.

12. The method of claim 1 , further comprising the step of:

changing said discharging step if said current flow rate differs from said target flow rate in a predetermined manner.

13. The method of claim 12 , further comprising the step of:

inputting said predetermined manner.

14. The method of claim 12 , wherein said discharging step uses a power injector, and wherein said method further comprises the step of:

allowing operator input of said predetermined manner.

15. The method of claim 12 , further comprising the step of:

executing a first prompting step comprising prompting an entry of said predetermined manner on at least one graphical user interface.

16. The method of claim 15 , further comprising the step of:

executing a second prompting step comprising prompting an entry of said target flow rate on at least one graphical user interface.

17. The method of claim 1 , further comprising the step of:

terminating said discharging step if said current flow rate is less than a predetermined percentage of said target flow rate.

18. The method of claim 1 , further comprising the step of:

terminating said discharging step if said current flow rate is less than said target flow rate by a predetermined value.

19. A method of operation for a medical fluid delivery system, the method comprising the steps of:

discharging medical fluid from said medical fluid delivery system in accordance with a phase of a fluid delivery protocol, wherein said phase is configured to deliver a programmed volume of said medical fluid at a programmed target flow rate; and

displaying a first output, wherein said first output comprises a numerical comparison between a current flow rate of said discharging step and said target flow rate, wherein said discharging step is executed in an attempt to provide said target flow rate, and wherein said displaying step is executed only when said current flow rate differs from said target flow rate by more than a predetermined amount.

20. A method of operation for a medical fluid delivery system, the method comprising the steps of:

discharging medical fluid from said medical fluid delivery system in accordance with a phase of a fluid delivery protocol, wherein said phase is configured to deliver a programmed volume of said medical fluid at a programmed target flow rate; and

displaying a first output, wherein said first output comprises a numerical comparison between a current flow rate of said discharging step and said target flow rate, wherein said discharging step is executed in an attempt to provide said target flow rate, and wherein said displaying step comprises expressing said current flow rate as a percentage of said target flow rate.

21. A method of operation for a medical fluid delivery system, the method comprising the steps of:

discharging medical fluid from said medical fluid delivery system in accordance with a phase of a fluid delivery protocol, wherein said phase is configured to deliver a programmed volume of said medical fluid at a programmed target flow rate;

displaying a first output, wherein said first output comprises a numerical comparison between a current flow rate of said discharging step and said target flow rate, and wherein said discharging step is executed in an attempt to provide said target flow rate; and

terminating said discharging step if said current flow rate is less than a predetermined percentage of said target flow rate.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2010
From: LAFFERTY, SEAN B.; WAGNER, GARY S.
To: MALLINCKRODT INC.
Reel/Frame 024386/0255 →